Author Archive

Leadership and Management Training Funding The 2024-25 PCN DES contract specification allows for a Leadership and Management payment, but this is now combined into the core PCN Funding. Please click...

Check out our wide variety of engaging and relevant online courses to meet the needs of Dispensing Doctors’ staff. Learn at your own pace!   For learner prices please click...

By Dispex Missed Dispensing Fees for Services Rendered If you kindly extend a selection of assorted flavours to your patients to ensure patient compliance and satisfaction, ensure you are compensated...

Category A products are generics which do not meet the threshold volumes to be included in Category M. From April 2024 and for the next 18 months, Category A prices,...

By Dispex NHS Prescription Charges from 1st May 2024 Charges for NHS prescriptions increased on the 1st May 2024. The National Health Service (Charges for Drugs and Appliances) (Amendment) Regulations...

Establishing a protocol for monitoring staff competency and education will foster an atmosphere of continue professional development and growth. Through regular assessments, training programs, and opportunities for further education, employees...

Drug Supply Page Dispex provides primary care focused updates on drug supply issues. Data is taken from the SPS website on a weekly basis. 3 new Unavailable 3 new Resolved Dispex...

Source: Practice Index  25th April 2024 In recent years, the explosive growth of artificial intelligence or AI-powered applications has brought about a transformative wave across various industries, and healthcare is...

Source: Practice Index 18.4.24 Another funding storm is on the horizon with the recently announced rise in national practice contract funding for England. For all the people working in general...

Understanding the PCSE Online Drug Statement   Keeping a watchful eye on your PCSE drug statements and prescription charges has always been an important aspect of best practice. However, in...

Source: MHRA /Gov.uk 23.4.24 (Cheplapharm – Canadian Livery), EL(24)A/14: Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure. MDR number MDR 191-04/24 Company...

Source: MHRA/Gov.uk 23.4.24 Risk of Early Revision, DSI/2024/005 The MHRA was alerted by Beyond Compliance and the UK National Joint Registry (NJR) to a significantly higher revision rate observed with...